UPDATE: Regeneron Pharma (REGN) PT Raised to $632 but Morgan Stanley Expects Little From Quarterly Results
Tweet Send to a Friend
(Updated - April 12, 2022 7:36 AM EDT)
Morgan Stanley analyst Matthew Harrison raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
